Page 1

Danaher Corporation Investors DANAHER REPORTS THIRD QUARTER 2021 RESULTS WASHINGTON , Oct. 21 , 2021 / PRNewswire / -- Danaher Corporation ( NYSE : DHR ) ( the " Company " ) today announced results for the third quarter 2021. All results in this release reflect only continuing operations unless otherwise noted . For the quarter ended October 1 , 2021 , net earnings were $ 1.2 billion , or $ 1.54 per diluted common share which represents a 33.0 % year over - year increase from the comparable 2020 period . Non - GAAP adjusted diluted net earnings per common share were $ 2.39 which represents a 39.0 % increase over the comparable 2020 period . Revenues increased 23.0 % year - over - year to $ 7.2 billion , with 20.5 % non - GAAP core revenue growth . Year - to - date operating cash flow was $ 6.0 billion , representing a 51.0 % increase year - over - year , and non - GAAP free cash flow was $ 5.2 billion , representing a 46.5 % increase year - over - year . For the fourth quarter 2021 , the Company anticipates that non - GAAP core revenue growth will be in the low - to - mid teens percent range . For the full year 2021 , the Company now anticipates that the non - GAAP core revenue growth rate including Cytiva will be more than 20 % . Rainer M. Blair , President and Chief Executive Offic stated , " Our team delivered another outstanding result in the third quarter , with over 20 % core revenue growth and terrific earnings and cash flow performance . We continued to invest for growth across our businesses , expanding production capacity and accelerating innovation initiatives . Additionally , the recently closed acquisition of Aldevron enhances our portfolio and expands our capabilities into the important field of genomic medicine . " Blair continued , " Our performance is a testament to the power of our portfolio and our team's commitment to the Danaher Business System , and we see significant opportunities ahead to continue building sustainable , long - term value for shareholders . " Danaher will discuss its results during its quarterly investor conference call today starting at 8:00 a.m. ET . The call and an accompanying slide presentation will be webcast on the " Investors " section of Danaher's website , www.danaher.com , under the subheading " Events & Presentations . " A replay of the webcast will be available in the same section of Danaher's website shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call . The conference call can be accessed by dialing 800-895-3361 within the U.S. or by dialing + 1-785-424-1062 outside the U.S. a few minutes before the 8:00 a.m. ET start and telling the operator that you are dialing in for Danaher's earnings conference call ( conference ID : DHRQ321 ) . A replay of the conference call will be available shortly after the conclusion of the call and until November 4 , 2021. You can access the replay dial - in information on the " Investors " section of Danaher's website under the subheading " Events & Presentations . " In addition , presentation materials relating to Danaher's results have been posted to the " Investors " section of Danaher's website under the subheading " Quarterly Earnings . " ABOUT DANAHER Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world . Its family of world class brands has leadership positions in the demanding and attractive health care , environmental and applied end - markets . With more than 20 operating companies , Danaher's globally diverse team of approximately 69,000 associates is united by a common culture and operating system , the Danaher Business System , and its Shared Purpose , Helping Realize Life's Potential . For more information , please visit www.danaher.com . NON - GAAP MEASURES In addition to the financial measures prepared in accordance with generally accepted accounting principles ( GAAP ) , this earnings release also